MUSTT

MUSTT

Abbreviation for:
Multicentre Unsustained Tachycardia Trial

MUSTT

Cardiology
1. A clinical study–Multicenter Unstable Tachycardia Trial.
2. A clinical study–Multicenter Unsustained Tachycardia Trial. See Calgary-MUSTT.
Mentioned in ?
References in periodicals archive ?
This measure has dramatically increased accuracy and accountability in tracking motorcycle riders across the wing and in MUSTT.
Zelenkofske also served as Director of CV Research and Clinical Director of Electrophysiology Laboratory at the Heart Care Group, where he was a physician investigator for a number of pivotal cardiovascular clinical trials, including SCD HeFT, COMPANION, MADIT, AVID and MUSTT.
35 MUSTT (1999) (22) 704 patients with ischemic Inducible, sustained cardiomyopathy and LVEF ventricular [less than or equal to] tachyarrhythmias 0.
At least 7 multicenter trials (MADIT, MUSTT, MADIT II, AVID, CASH, CIDS, and DINAMIT) have demonstrated that ICDs are more effective than any antiarrhythmic drug in decreasing the mortality rate (15, 16).
Previous trials, including MADIT, MUSTT and AVID, have demonstrated that implantable defibrillators improve survival in other patient populations.
He has served as a physician investigator for a number of pivotal cardiovascular clinical trials, including SCD HeFT, COMPANION, MADIT, AVID and MUSTT.
In addition to COMPANION, MADIT II and MUSTT, other Guidant solely or jointly sponsored trials include MADIT, CONTAK CD(R) and AVID.
The multi-center study is comprised of the same patient population observed in the previously completed MADIT and MUSTT studies, which demonstrated the benefits of ICD technology, but used EP testing to select the patients.
Earlier trials such as MADIT and MUSTT have demonstrated a significant impact on clinical practice around the world.
Illinois Masonic was one of only four sites in Chicago that participated in MUSTT.
The DEBUT trial builds on the results of other landmark studies, such as MADIT, AVID, and MUSTT, that demonstrate the lifesaving value of implantable defibrillation therapy," said Fred McCoy, president, cardiac rhythm management, Guidant Corporation.